{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:42:16Z","timestamp":1773240136429,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T00:00:00Z","timestamp":1349395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s11033-012-1957-5","type":"journal-article","created":{"date-parts":[[2012,10,4]],"date-time":"2012-10-04T16:54:38Z","timestamp":1349369678000},"page":"10671-10679","source":"Crossref","is-referenced-by-count":11,"title":["Associations between the FAS \u2212670\u00a0A\/G and \u22121,377\u00a0G\/A polymorphisms and susceptibility to autoimmune rheumatic diseases: a meta-analysis"],"prefix":"10.1007","volume":"39","author":[{"given":"Young Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Cheol","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Jae","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Dae","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwan Gyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,5]]},"reference":[{"key":"1957_CR1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/90935","volume":"7","author":"P Marrack","year":"2001","unstructured":"Marrack P, Kappler J, Kotzin BL (2001) Autoimmune disease: why and where it occurs. Nature Med 7:899\u2013905","journal-title":"Nature Med"},{"key":"1957_CR2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0306-9877(03)00332-3","volume":"62","author":"KG Becker","year":"2004","unstructured":"Becker KG (2004) The common variants\/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 62:309\u2013317","journal-title":"Med Hypotheses"},{"key":"1957_CR3","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2337\/diabetes.48.7.1353","volume":"48","author":"KG Becker","year":"1999","unstructured":"Becker KG (1999) Comparative genetics of type 1 diabetes and autoimmune disease\u2014Common loci, common pathways? Diabetes 48:1353\u20131358","journal-title":"Diabetes"},{"key":"1957_CR4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00439-005-0073-1","volume":"118","author":"YH Lee","year":"2005","unstructured":"Lee YH, Nath SK (2005) Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet 118:434\u2013443","journal-title":"Hum Genet"},{"key":"1957_CR5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/rheumatology\/kei128","volume":"45","author":"SJ Choi","year":"2006","unstructured":"Choi SJ, Rho YH, Ji JD, Song GG, Lee YH (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45:166\u2013170","journal-title":"Rheumatology (Oxford)"},{"key":"1957_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0167-5699(95)80079-4","volume":"16","author":"DH Lynch","year":"1995","unstructured":"Lynch DH, Ramsdell F, Alderson MR (1995) Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569\u2013574","journal-title":"Immunol Today"},{"key":"1957_CR7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0952-7915(94)90102-3","volume":"6","author":"PH Krammer","year":"1994","unstructured":"Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM (1994) Regulation of apoptosis in the immune system. Curr Opin Immunol 6:279\u2013289","journal-title":"Curr Opin Immunol"},{"key":"1957_CR8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0092-8674(91)90614-5","volume":"66","author":"N Itoh","year":"1991","unstructured":"Itoh N, Yonehara S, Ishii A et al (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233\u2013243","journal-title":"Cell"},{"key":"1957_CR9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0161-5890(97)00081-3","volume":"34","author":"QR Huang","year":"1997","unstructured":"Huang QR, Morris D, Manolios N (1997) Identification and characterization of polymorphisms in the promoter region of the human Apo-1\/Fas (CD95) gene. Mol Immunol 34:577\u2013582","journal-title":"Mol Immunol"},{"key":"1957_CR10","first-page":"4327","volume":"63","author":"K Sibley","year":"2003","unstructured":"Sibley K, Rollinson S, Allan JM et al (2003) Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res 63:4327\u20134330","journal-title":"Cancer Res"},{"key":"1957_CR11","doi-asserted-by":"crossref","unstructured":"Molin S, Weiss EH, Ruzicka T, Messer G (2012) The FAS\/cd95 promoter single-nucleotide polymorphism -670 A\/G and lupus erythematosus. Clin Exp Dermatol 2012 [ http:\/\/dx.doi.org\/10.1111\/j.1365-2230.2011.04296.x ] (in press)","DOI":"10.1111\/j.1365-2230.2011.04296.x"},{"key":"1957_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/08820130903401736","volume":"39","author":"JM Arasteh","year":"2010","unstructured":"Arasteh JM, Sarvestani EK, Aflaki E, Amirghofran Z (2010) Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules. Immunol Invest 39:27\u201338","journal-title":"Immunol Invest"},{"key":"1957_CR13","first-page":"1183","volume":"29","author":"S Kanemitsu","year":"2002","unstructured":"Kanemitsu S, Ihara K, Saifddin A et al (2002) A functional polymorphism in fas (CD95\/APO-1) gene promoter associated with systemic lupus erythematosus. J Rheumatol 29:1183\u20131188","journal-title":"J Rheumatol"},{"key":"1957_CR14","first-page":"2008","volume":"28","author":"YH Lee","year":"2001","unstructured":"Lee YH, Kim YR, Ji JD, Sohn J, Song GG (2001) Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus. J Rheumatol 28:2008\u20132011","journal-title":"J Rheumatol"},{"key":"1957_CR15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/38.9.883","volume":"38","author":"G Coakley","year":"1999","unstructured":"Coakley G, Manolios N, Loughran TP Jr, Panayi GS, Lanchbury JS (1999) A Fas promoter polymorphism at position -670 in the enhancer region does not confer susceptibility to Felty\u2019s and large granular lymphocyte syndromes. Rheumatology (Oxford) 38:883\u2013886","journal-title":"Rheumatology (Oxford)"},{"key":"1957_CR16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/ard.2008.088989","volume":"68","author":"V Liakouli","year":"2009","unstructured":"Liakouli V, Manetti M, Pacini A et al (2009) The \u2212670\u00a0G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. Ann Rheum Dis 68:584\u2013590","journal-title":"Ann Rheum Dis"},{"key":"1957_CR17","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/art.24964","volume":"60","author":"J Broen","year":"2009","unstructured":"Broen J, Gourh P, Rueda B et al (2009) The FAS \u2212670A >G polymorphism influences susceptibility to systemic sclerosis phenotypes. Arthritis Rheum 60:3815\u20133820","journal-title":"Arthritis Rheum"},{"key":"1957_CR18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/ard.2003.006056","volume":"63","author":"CG Mullighan","year":"2004","unstructured":"Mullighan CG, Heatley S, Lester S, Rischmueller M, Gordon TP, Bardy PG (2004) Fas gene promoter polymorphisms in primary Sjogren\u2019s syndrome. Ann Rheum Dis 63:98\u2013101","journal-title":"Ann Rheum Dis"},{"key":"1957_CR19","first-page":"2397","volume":"27","author":"AI Bolstad","year":"2000","unstructured":"Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R (2000) Fas and Fas ligand gene polymorphisms in primary Sjogren\u2019s syndrome. J Rheumatol 27:2397\u20132405","journal-title":"J Rheumatol"},{"key":"1957_CR20","first-page":"166","volume":"29","author":"R Donn","year":"2002","unstructured":"Donn R, Zeggini E, Shelley E, Ollier W, Thomson W (2002) Lack of association between juvenile idiopathic arthritis and fas gene polymorphism. J Rheumatol 29:166\u2013168","journal-title":"J Rheumatol"},{"key":"1957_CR21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s100670170007","volume":"20","author":"YH Lee","year":"2001","unstructured":"Lee YH, Ji JD, Sohn J, Song GG (2001) Polymorphsims of CTLA-4 exon 1 +49, CTLA-4 promoter -318 and Fas promoter \u2212670 in spondyloarthropathies. Clin Rheumatol 20:420\u2013422","journal-title":"Clin Rheumatol"},{"key":"1957_CR22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/003130200104376","volume":"32","author":"QR Huang","year":"2000","unstructured":"Huang QR, Manolios N (2000) Investigation of the -1377 polymorphism on the Apo-1\/Fas promoter in systemic lupus erythematosus patients using allele-specific amplification. Pathology 32:126\u2013130","journal-title":"Pathology"},{"key":"1957_CR23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/sj.ejhg.5201566","volume":"14","author":"YH Lee","year":"2006","unstructured":"Lee YH, Harley JB, Nath SK (2006) Meta-analysis of TNF-alpha promoter -308 A\/G polymorphism and SLE susceptibility. Eur J Hum Genet 14:364\u2013371","journal-title":"Eur J Hum Genet"},{"key":"1957_CR24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00296-006-0175-7","volume":"27","author":"YH Lee","year":"2006","unstructured":"Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2006) Association of TNF-alpha -308 G\/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int 27:157\u2013161","journal-title":"Rheumatol Int"},{"key":"1957_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/kel170","volume":"46","author":"YH Lee","year":"2007","unstructured":"Lee YH, Rho YH, Choi SJ et al (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases\u2014a meta-analysis. Rheumatology (Oxford) 46:49\u201356","journal-title":"Rheumatology (Oxford)"},{"key":"1957_CR26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"1957_CR27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"1957_CR28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"1957_CR29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3904\/kjim.2010.25.3.317","volume":"25","author":"HR Kim","year":"2010","unstructured":"Kim HR, Park MK, Cho ML et al (2010) Induction of macrophage migration inhibitory factor in ConA-stimulated rheumatoid arthritis synovial fibroblasts through the P38 map kinase-dependent signaling pathway. Korean J Intern Med 25:317\u2013326","journal-title":"Korean J Intern Med"},{"key":"1957_CR30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3109\/02656739609027683","volume":"12","author":"SV Kozin","year":"1996","unstructured":"Kozin SV, Hasegawa T, Kozina LV et al (1996) The use of a hypoxic cell radiosensitizer AK-2123 gave no improvement in thermoradiotherapy combined with hydralazine. Int J Hyperthermia 12:771\u2013777","journal-title":"Int J Hyperthermia"},{"key":"1957_CR31","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.4049\/jimmunol.159.11.5309","volume":"159","author":"RA Salmon","year":"1997","unstructured":"Salmon RA, Foltz IN, Young PR, Schrader JW (1997) The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors. J Immunol 159:5309\u20135317","journal-title":"J Immunol"},{"key":"1957_CR32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","volume":"88","author":"S Nagata","year":"1997","unstructured":"Nagata S (1997) Apoptosis by death factor. Cell 88:355\u2013365","journal-title":"Cell"},{"key":"1957_CR33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1272\/jnms1923.64.459","volume":"64","author":"S Nagata","year":"1997","unstructured":"Nagata S (1997) Apoptosis mediated by Fas and its related diseases. Nihon Ika Daigaku Zasshi 64:459\u2013462","journal-title":"Nihon Ika Daigaku Zasshi"},{"key":"1957_CR34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1744-313X.2007.00676.x","volume":"34","author":"W Mahfoudh","year":"2007","unstructured":"Mahfoudh W, Bel Hadj Jrad B, Romdhane A, Chouchane L (2007) A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels. Int J Immunogenet 34:209\u2013212","journal-title":"Int J Immunogenet"},{"key":"1957_CR35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00296-010-1633-9","volume":"32","author":"M Sahebari","year":"2012","unstructured":"Sahebari M, Rezaieyazdi Z, Nakhjavani MJ, Hatef M, Mahmoudi M, Akhlaghi S (2012) Correlation between serum concentrations of soluble Fas (CD95\/Apo-1) and IL-18 in patients with systemic lupus erythematosus. Rheumatol Int 32:601\u2013606","journal-title":"Rheumatol Int"},{"key":"1957_CR36","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.7510905","volume":"263","author":"J Cheng","year":"1994","unstructured":"Cheng J, Zhou T, Liu C et al (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759\u20131762","journal-title":"Science"},{"key":"1957_CR37","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.4049\/jimmunol.156.12.4622","volume":"156","author":"G Papoff","year":"1996","unstructured":"Papoff G, Cascino I, Eramo A, Starace G, Lynch DH, Ruberti G (1996) An N-terminal domain shared by Fas\/Apo-1 (CD95) soluble variants prevents cell death in vitro. J Immunol 156:4622\u20134630","journal-title":"J Immunol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-012-1957-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1957-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T02:23:11Z","timestamp":1687746191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-012-1957-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,5]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1957"],"URL":"https:\/\/doi.org\/10.1007\/s11033-012-1957-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,5]]}}}